Related Experiment Video
Updated: Dec 1, 2025

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
Transmembrane protein ADAM29 facilitates cell proliferation, invasion and migration in clear cell renal cell
Shun-Lai Li1, Ting-Qi Jiang1, Qing-Wei Cao2
1Department of Urology, The Fifth People's Hospital of Jinan, Jinan, P.R. China.
Abstract:
Abnormal expression of ADAM29 has been frequently reported in several cancers, however, its role in clear cell renal cell carcinoma (ccRCC) has not evaluated in detail. Herein, we attempt to determine the biological role and the action mechanism of ADAM29 in ccRCC. Bioinformatics analysis based on the ccRCC RNA-Seq dataset from TCGA database revealed that ADAM29 was up-expressed in ccRCC tissues by comparison with normal tissues. And a significant increase of ADAM29 expression was also observed in 3 ccRCC cell lines (UT33A, Caki-1, and786-O) in comparison with normal cell line. Besides, high level of ADAM29 was found to be connected with the poor prognosis and could be considered as an independent prognosticator for patients with ccRCC. Furthermore, functional experiments in vitro demonstrated that ADAM29 promoted the growth, invasion and migration of ccRCC cells. Moreover, Western blot assays indicated that ADAM29 was positively correlated with the level of proliferation-related proteins Cyclin D1 and PCNA and motion-related proteins MMP9 and Snail. Our data indicate that ADAM29 acts as an oncogene that increases tumour cells proliferation, invasion and migration partly by regulating the expression of Cyclin D1/PCNA/MMP9/Snail, suggesting that ADAM29 may become a prognosticator and therapeutic candidate for ccRCC.
Insights
ADAM29 is overexpressed in clear cell renal cell carcinoma (ccRCC), promoting tumor growth and metastasis. This finding suggests ADAM29 could serve as a prognosticator and therapeutic target for ccRCC patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- ADAM29 (a disintegrin and metalloproteinase domain) expression is altered in various cancers.
- Its specific role in clear cell renal cell carcinoma (ccRCC) remains largely uninvestigated.
Purpose of the Study:
- To elucidate the biological function and mechanism of ADAM29 in ccRCC.
- To assess ADAM29 as a potential prognostic marker for ccRCC.
Main Methods:
- Bioinformatic analysis of TCGA ccRCC RNA-Seq dataset.
- In vitro functional experiments (cell growth, invasion, migration assays).
- Western blot analysis for protein expression (Cyclin D1, PCNA, MMP9, Snail).
Main Results:
- ADAM29 is significantly upregulated in ccRCC tissues and cell lines compared to normal controls.
- High ADAM29 expression correlates with poor prognosis and serves as an independent prognosticator.
- ADAM29 promotes ccRCC cell proliferation, invasion, and migration.
- ADAM29 positively correlates with proliferation markers (Cyclin D1, PCNA) and migration markers (MMP9, Snail).
Conclusions:
- ADAM29 functions as an oncogene in ccRCC.
- It enhances tumor cell proliferation, invasion, and migration by regulating Cyclin D1/PCNA/MMP9/Snail pathways.
- ADAM29 presents a promising prognosticator and therapeutic target for ccRCC.
Related Concept Videos
Cancer Cell Migration through Invadopodia
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Abnormal Proliferation
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
PI3K/mTOR/AKT Signaling Pathway

